针对线粒体的小分子作为癌症治疗的创新方法
Omkar S Kamble1, Rana Chatterjee1, K G Abishek1
1Department of Industrial and Engineering Chemistry, Institute of Chemical Technology, Indian Oil Odisha Campus, Samantpuri, Bhubaneswar 751013, India.
癌细胞逃避细胞死亡,减少治疗的有效性. 本综述探讨了用小分子 (mitocans) 向线粒体,以克服这种抵抗并改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 癌细胞逃避被编程细胞死亡,这是治疗失败的关键因素.
- 线粒体对于细胞能量至关重要,还包含细胞死亡的机制.
- 线粒体功能障碍是癌细胞的标志,具有治疗脆弱性.
研究的目的:
- 审查在癌症治疗中准线粒体的理由和机制.
- 突出小分子的作用,称为"mitocans",在癌症治疗中.
- 为了检查各种各样的小分子类型,以了解它们作为癌症治疗的潜力.
主要方法:
- 文献综述专注于癌症中的线粒体向策略.
- 设计用于与线粒体相互作用的小分子的分析.
- 检查这些分子对癌细胞生理学的影响.
主要成果:
- 线粒体向提供了一个有希望的策略,以克服癌症逃避细胞死亡.
- 小分子 (线粒体) 可以选择性地传递到线粒体,诱导癌细胞死亡.
- 各种类型的小分子显示出在癌症中调节线粒体功能的潜力.
结论:
- 用小分子向线粒体代表了癌症治疗的新有效方法.
- 线粒体可以被设计为利用特定于癌症的线粒体漏洞.
- 对各种小分子线粒体的进一步研究可能会导致改善癌症治疗方法.
更多相关视频
07:49Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
